Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Marker Therapeutics, Inc.

NASDAQ: MRKR · Life Sciences · 2 alerts · CIK 1094038

Share price
$0.8286Close, Nov 16
Market cap
$13.8M
Shares outstanding
16.67MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Marker Therapeutics, Inc. filings on SEC EDGAR ↗

4:44 PM ET 10-Q
Financial Results

Marker Therapeutics Q3 2026 Results: Net Loss of $1.84M, Loss Narrows

Marker Therapeutics, Inc. reported financial results for the quarter ended September 30, 2026, highlighting continued progress in its clinical-stage cell therapy pipeline. The company maintained a net loss as it invests in R&D, with sufficient cash reserves to support operations into the following year.

Key figure
Net loss $1.84M

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.